Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Retained Earnings (2023 - 2025)

Rallybio's Retained Earnings history spans 3 years, with the latest figure at -$296.1 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 175334.32% year-over-year to -$296.1 million; the TTM value through Sep 2025 reached -$296.1 million, down 175334.32%, while the annual FY2024 figure was -$293.0 million, 24.56% down from the prior year.
  • Retained Earnings for Q3 2025 was -$296.1 million at Rallybio, up from -$312.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $169000.0 in Q3 2024 and bottomed at -$312.2 million in Q2 2025.
  • The 3-year median for Retained Earnings is -$254.3 million (2024), against an average of -$214.3 million.
  • The largest annual shift saw Retained Earnings surged 100.08% in 2024 before it plummeted 175334.32% in 2025.
  • A 3-year view of Retained Earnings shows it stood at -$235.2 million in 2023, then decreased by 24.56% to -$293.0 million in 2024, then decreased by 1.07% to -$296.1 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Retained Earnings are -$296.1 million (Q3 2025), -$312.2 million (Q2 2025), and -$302.5 million (Q1 2025).